Back to Search
RYAN SYLVESTER, PHARMD
PHARMD
Pharmacist
NPI: 1376917450Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
14738(OR)
Research & Publications (20)
The schedule and duration of intravesical chemotherapy in patients with non-muscle-invasive bladder cancer: a systematic review of the published results of randomized clinical trials.
PMID 18207317·Eur Urol·2008
1-meta
Editorial comment on: prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trials.
PMID 17950990·Eur Urol·2008
8-other
Combining a molecular profile with a clinical and pathological profile: biostatistical considerations.
PMID 18815933·Scand J Urol Nephrol Suppl·2008
6-review
Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.
PMID 16442208·Eur Urol·2006
8-other
Natural history, recurrence, and progression in superficial bladder cancer.
PMID 17619739·ScientificWorldJournal·2006
6-review
High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder.
PMID 16399418·Urology·2005
6-review
Bacillus calmette-guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials.
PMID 15947584·J Urol·2005
4-observational
A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials.
PMID 15126782·J Urol·2004
1-meta
The side effects of Bacillus Calmette-Guerin in the treatment of Ta T1 bladder cancer do not predict its efficacy: results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial.
PMID 14499675·Eur Urol·2003
3-trial
Clinical applications of colony-stimulating factors: a historical perspective.
PMID 11944613·Am J Health Syst Pharm·2002
6-review
Ten years of colony-stimulating factors: what have we learned? Introduction.
PMID 11944612·Am J Health Syst Pharm·2002
6-review
Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials.
PMID 12394686·J Urol·2002
4-observational
Statistical methodology of phase III cancer clinical trials: advances and future perspectives.
PMID 11858987·Eur J Cancer·2002
8-other
The role of adjuvant combination chemotherapy after cystectomy in locally advanced bladder cancer: what we do not know and why.
PMID 10997813·Ann Oncol·2000
8-other
Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy.
PMID 19576682·Eur Urol·2009
6-review
Analysis of Rex1 (zfp42) function in embryonic stem cell differentiation.
PMID 19618472·Dev Dyn·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3181 SW SAM JACKSON PARK RD
PORTLAND, OR 97239 - Phone
- (503) 418-5241
Quick Facts
- NPI
- 1376917450
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile